Exogenous Antigen Presentation Pathway via MHC II Processing

Added:

Challenging the Classical MHC Dichotomy: Autophagy and Cross-Presentation

While classical immunology teaches a strict division of labor—where exogenous antigens are exclusively presented on MHC Class II to CD4+ T cells and endogenous antigens on MHC Class I to CD8+ T cells—this dichotomy is challenged by alternative pathways. Specifically, autophagy allows endogenous (intracellular) proteins, such as cytosolic and organelle-derived antigens, to be delivered to the endolysosomal compartment and loaded onto MHC Class II molecules for CD4+ T cell activation. Conversely, 'cross-presentation' allows dendritic cells to divert exogenous antigens into the MHC Class I pathway to stimulate CD8+ T cells. These non-classical pathways demonstrate that antigen processing is highly fluid, proving that MHC Class II presentation is not strictly limited to exogenous sources, and revealing a more integrated and complex system of immune surveillance than the traditional compartmentalized model suggests.

Basic structure and function of the Major Histocompatibility Complex (MHC), specifically distinguishing between Class I and Class II molecules.
The role and identity of professional Antigen-Presenting Cells (APCs) such as dendritic cells, macrophages, and B cells.
Fundamental cellular processes of endocytosis, phagocytosis, and vesicle fusion (phagolysosome formation).
An introduction to T-lymphocyte biology, specifically the distinction between CD4+ helper T cells and CD8+ cytotoxic T cells.
The endogenous antigen presentation pathway via MHC Class I to CD8+ T cells for comparative analysis.
The downstream activation mechanism of CD4+ T cells, including TCR binding, co-stimulation (e.g., CD28/B7), and subsequent cytokine secretion.
The phenomenon of 'cross-presentation', where exogenous antigens are diverted to the MHC Class I pathway.
Medical and clinical applications, including vaccine design strategies that target MHC II pathways and pathogen evasion mechanisms (such as blocking phagolysosome fusion).
94.6K views2.6Klikes4:57@hussainbiologyOriginal Release: 2019-07-23

In the exogenous pathway of antigen presentation, extracellular pathogens are internalized through phagocytosis, forming phagosomes that fuse with lysosomes to create phagolysosomes where acidic conditions activate hydrolytic enzymes that degrade pathogens into peptides; simultaneously, MHC II molecules are synthesized in the ER, associate with invariant chain (Ii/CD74) to prevent premature peptide binding, are transported to the Golgi, and then to endosomes where cathepsins degrade the invariant chain to leave CLIP; HLA-DM then removes CLIP to expose the MHC II binding site, allowing antigen peptides to load onto MHC II before the complex is transported to the cell surface for recognition by CD4+ T helper cells.